Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin
AimOvercoming therapy resistance is critical for effective melanoma control. Upregulation of Rho/MRTF signaling in human and mouse melanomas causes resistance to targeted therapies. Inhibition of this pathway by MRTFi, CCG-257081 resensitized resistant melanomas to BRAF and MEK inhibitors. It also p...
Saved in:
Main Authors: | Bardees M. Foda, Annika E. Baker, Łukasz Joachimiak, Marzena Mazur, Richard R. Neubig |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1505000/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea
by: Joon Min Jung, et al.
Published: (2025-01-01) -
Advances in Cell and Immune Therapies for Melanoma
by: Tanase Timis, et al.
Published: (2025-01-01) -
A rare case of malignant melanoma presenting as anterior-superior mediastinal mass
by: Dario Familiari, MD, et al.
Published: (2025-03-01) -
Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells
by: Ceyda Colakoglu Bergel, et al.
Published: (2025-01-01) -
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)